MDT vs TT
Medtronic PLC and Trane Technologies PLC, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | MDT | TT |
|---|---|---|
| Revenue | $36.4B | $21.3B |
| Net income | $4.8B | $2.9B |
| Gross margin | 65.0% | 30.5% |
| Net margin | 13.2% | 13.7% |
| Return on equity | 9.8% | 36.4% |
| Diluted EPS | $3.73 | $12.98 |
| Dividend / share | $2.84 | $3.76 |
| Payout ratio | 75.8% | 28.7% |
| Free cash flow | $5.4B | $2.8B |
| Equity | $49.5B | $8.6B |
| Net debt / equity | 0.53× | 0.33× |
| Current ratio | 2.13× | 1.25× |
| Revenue CAGR 5y | 3.8% | 11.4% |
| Profit CAGR 5y | 5.9% | 27.8% |
MDT bills 1.7× the revenue of TT, and TT keeps more of each dollar of revenue as profit (13.7% against 13.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | MDT | TT |
|---|---|---|
| FY2025 | $36.4B | $21.3B |
| FY2024 | $33.5B | $19.8B |
| FY2023 | $32.4B | $17.7B |
| FY2022 | $31.2B | $16.0B |
| FY2021 | $31.7B | $14.1B |
| FY2020 | $30.1B | $12.5B |
| FY2019 | $28.9B | $13.1B |
| FY2018 | $30.6B | $12.3B |
| FY2017 | $30.0B | $14.2B |
| FY2016 | $29.7B | $13.5B |
Net income by year
Bottom line
| Fiscal year | MDT | TT |
|---|---|---|
| FY2025 | $4.8B | $2.9B |
| FY2024 | $4.7B | $2.6B |
| FY2023 | $3.7B | $2.0B |
| FY2022 | $3.8B | $1.8B |
| FY2021 | $5.0B | $1.4B |
| FY2020 | $3.6B | $854.9M |
| FY2019 | $4.8B | $1.4B |
| FY2018 | $4.6B | $1.3B |
| FY2017 | $3.1B | $1.3B |
| FY2016 | $4.0B | $1.5B |
Advertisement
AdSense · Rectangle 336×280